Molecular analysis of CYP1B1 in Omani patients with primary congenital glaucoma: A pilot study

Stefan El-Gayar, Anuradha Ganesh, Gabriela Chavarria-Soley, Sana Al-Zuhaibi, Rayhanah Al-Mjeni, Sandy Raeburn, Alexander A. Bialasiewicz

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Purpose: To screen cytochrome P4501B1 (CYP1B1) for causative mutations in Omani patients with a clinical diagnosis of primary congenital glaucoma (PCG). Methods: Nine PCG families were recruited for the study. All patients underwent detailed clinical examinations to confirm the diagnosis of PCG. The families of index patients were also examined. Genealogical information was obtained by pedigree analysis. The primary candidate gene, CYP1B1, was amplified from genomic DNA, sequenced, and analyzed in patients to identify the disease-causing mutations. Results: Eight of the nine PCG families were consanguineous (89%). Molecular analysis of CYP1B1 showed three distinct mutations, p.G61E, p.D374N, and p.R368H, in seven of nine unrelated PCG index patients (78%). Six patients had homozygous mutations and one had a compound heterozygous mutation. Causative mutations were not identified in two families. In family 4, the index patient was found to be heterozygous for the p.E229K variant. In family 6, although affected individuals were found to be homozygous in the CYP1B1 region, no mutation could be identified. Conclusions: This study indicates that CYP1B1 could be the predominant cause of PCG in the Omani population (78%). Omani PCG patients show allelic heterogeneity. Further studies are needed to delineate the spectrum of CYP1B1 mutations in Omani PCG families and to identify new or modifier genes contributing to the manifestations of PCG in this region.

Original languageEnglish
Pages (from-to)1325-1331
Number of pages7
JournalMolecular Vision
Volume15
Publication statusPublished - 2009

Fingerprint

Glaucoma
Mutation
Modifier Genes
Cytochrome P-450 CYP1B1
Pedigree
DNA
Population
Genes

ASJC Scopus subject areas

  • Ophthalmology

Cite this

El-Gayar, S., Ganesh, A., Chavarria-Soley, G., Al-Zuhaibi, S., Al-Mjeni, R., Raeburn, S., & Bialasiewicz, A. A. (2009). Molecular analysis of CYP1B1 in Omani patients with primary congenital glaucoma: A pilot study. Molecular Vision, 15, 1325-1331.

Molecular analysis of CYP1B1 in Omani patients with primary congenital glaucoma : A pilot study. / El-Gayar, Stefan; Ganesh, Anuradha; Chavarria-Soley, Gabriela; Al-Zuhaibi, Sana; Al-Mjeni, Rayhanah; Raeburn, Sandy; Bialasiewicz, Alexander A.

In: Molecular Vision, Vol. 15, 2009, p. 1325-1331.

Research output: Contribution to journalArticle

El-Gayar, S, Ganesh, A, Chavarria-Soley, G, Al-Zuhaibi, S, Al-Mjeni, R, Raeburn, S & Bialasiewicz, AA 2009, 'Molecular analysis of CYP1B1 in Omani patients with primary congenital glaucoma: A pilot study', Molecular Vision, vol. 15, pp. 1325-1331.
El-Gayar, Stefan ; Ganesh, Anuradha ; Chavarria-Soley, Gabriela ; Al-Zuhaibi, Sana ; Al-Mjeni, Rayhanah ; Raeburn, Sandy ; Bialasiewicz, Alexander A. / Molecular analysis of CYP1B1 in Omani patients with primary congenital glaucoma : A pilot study. In: Molecular Vision. 2009 ; Vol. 15. pp. 1325-1331.
@article{a8672af71c424141abe325babd7ef08d,
title = "Molecular analysis of CYP1B1 in Omani patients with primary congenital glaucoma: A pilot study",
abstract = "Purpose: To screen cytochrome P4501B1 (CYP1B1) for causative mutations in Omani patients with a clinical diagnosis of primary congenital glaucoma (PCG). Methods: Nine PCG families were recruited for the study. All patients underwent detailed clinical examinations to confirm the diagnosis of PCG. The families of index patients were also examined. Genealogical information was obtained by pedigree analysis. The primary candidate gene, CYP1B1, was amplified from genomic DNA, sequenced, and analyzed in patients to identify the disease-causing mutations. Results: Eight of the nine PCG families were consanguineous (89{\%}). Molecular analysis of CYP1B1 showed three distinct mutations, p.G61E, p.D374N, and p.R368H, in seven of nine unrelated PCG index patients (78{\%}). Six patients had homozygous mutations and one had a compound heterozygous mutation. Causative mutations were not identified in two families. In family 4, the index patient was found to be heterozygous for the p.E229K variant. In family 6, although affected individuals were found to be homozygous in the CYP1B1 region, no mutation could be identified. Conclusions: This study indicates that CYP1B1 could be the predominant cause of PCG in the Omani population (78{\%}). Omani PCG patients show allelic heterogeneity. Further studies are needed to delineate the spectrum of CYP1B1 mutations in Omani PCG families and to identify new or modifier genes contributing to the manifestations of PCG in this region.",
author = "Stefan El-Gayar and Anuradha Ganesh and Gabriela Chavarria-Soley and Sana Al-Zuhaibi and Rayhanah Al-Mjeni and Sandy Raeburn and Bialasiewicz, {Alexander A.}",
year = "2009",
language = "English",
volume = "15",
pages = "1325--1331",
journal = "Molecular Vision",
issn = "1090-0535",

}

TY - JOUR

T1 - Molecular analysis of CYP1B1 in Omani patients with primary congenital glaucoma

T2 - A pilot study

AU - El-Gayar, Stefan

AU - Ganesh, Anuradha

AU - Chavarria-Soley, Gabriela

AU - Al-Zuhaibi, Sana

AU - Al-Mjeni, Rayhanah

AU - Raeburn, Sandy

AU - Bialasiewicz, Alexander A.

PY - 2009

Y1 - 2009

N2 - Purpose: To screen cytochrome P4501B1 (CYP1B1) for causative mutations in Omani patients with a clinical diagnosis of primary congenital glaucoma (PCG). Methods: Nine PCG families were recruited for the study. All patients underwent detailed clinical examinations to confirm the diagnosis of PCG. The families of index patients were also examined. Genealogical information was obtained by pedigree analysis. The primary candidate gene, CYP1B1, was amplified from genomic DNA, sequenced, and analyzed in patients to identify the disease-causing mutations. Results: Eight of the nine PCG families were consanguineous (89%). Molecular analysis of CYP1B1 showed three distinct mutations, p.G61E, p.D374N, and p.R368H, in seven of nine unrelated PCG index patients (78%). Six patients had homozygous mutations and one had a compound heterozygous mutation. Causative mutations were not identified in two families. In family 4, the index patient was found to be heterozygous for the p.E229K variant. In family 6, although affected individuals were found to be homozygous in the CYP1B1 region, no mutation could be identified. Conclusions: This study indicates that CYP1B1 could be the predominant cause of PCG in the Omani population (78%). Omani PCG patients show allelic heterogeneity. Further studies are needed to delineate the spectrum of CYP1B1 mutations in Omani PCG families and to identify new or modifier genes contributing to the manifestations of PCG in this region.

AB - Purpose: To screen cytochrome P4501B1 (CYP1B1) for causative mutations in Omani patients with a clinical diagnosis of primary congenital glaucoma (PCG). Methods: Nine PCG families were recruited for the study. All patients underwent detailed clinical examinations to confirm the diagnosis of PCG. The families of index patients were also examined. Genealogical information was obtained by pedigree analysis. The primary candidate gene, CYP1B1, was amplified from genomic DNA, sequenced, and analyzed in patients to identify the disease-causing mutations. Results: Eight of the nine PCG families were consanguineous (89%). Molecular analysis of CYP1B1 showed three distinct mutations, p.G61E, p.D374N, and p.R368H, in seven of nine unrelated PCG index patients (78%). Six patients had homozygous mutations and one had a compound heterozygous mutation. Causative mutations were not identified in two families. In family 4, the index patient was found to be heterozygous for the p.E229K variant. In family 6, although affected individuals were found to be homozygous in the CYP1B1 region, no mutation could be identified. Conclusions: This study indicates that CYP1B1 could be the predominant cause of PCG in the Omani population (78%). Omani PCG patients show allelic heterogeneity. Further studies are needed to delineate the spectrum of CYP1B1 mutations in Omani PCG families and to identify new or modifier genes contributing to the manifestations of PCG in this region.

UR - http://www.scopus.com/inward/record.url?scp=67650514321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650514321&partnerID=8YFLogxK

M3 - Article

C2 - 19597567

AN - SCOPUS:67650514321

VL - 15

SP - 1325

EP - 1331

JO - Molecular Vision

JF - Molecular Vision

SN - 1090-0535

ER -